Your session is about to expire
← Back to Search
Incorporating CV Risk Assessment in AYA Visits
N/A
Waitlist Available
Led By Holly Gooding, MD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 month post-enrollment
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to test the #HerHeart web tool, which helps young women aged 13-21 understand their heart disease risk and adopt healthier habits. The tool provides information and tips to encourage a heart-healthy lifestyle.
Eligible Conditions
- Cardiovascular Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3 month post-enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 month post-enrollment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
#HerHEART Risk Score in AYA From Baseline
Alcohol Consumption
Cereal Fiber
+7 moreSecondary study objectives
BMI From Baseline
Diastolic Blood Pressure (BP) From Baseline
Systolic Blood Pressure (BP) From Baseline
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: AYA participantsExperimental Treatment1 Intervention
AYA participants will complete a brief initial survey consisting of demographic information and the Visual Analog Scale (VAS) and the #HerHeart tool in clinic. AYA participants will the rate the usability of the #HerHeart tool using the Website Analysis and Measurement Inventory (WAMMI), the likelihood they would recommend the app to their friends, and the likelihood of behavior change. AYA participants will then be offered the opportunity to continue into the 3-month intervention phase.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
#HerHeart tool
2022
N/A
~60
Find a Location
Who is running the clinical trial?
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,938 Previous Clinical Trials
47,792,238 Total Patients Enrolled
Emory UniversityLead Sponsor
1,704 Previous Clinical Trials
2,607,238 Total Patients Enrolled
Holly Gooding, MDPrincipal InvestigatorEmory University